Delivery Order SPE2DB20D7059-SPE2DB25FQBC5

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,346.28, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 10, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,852.90, is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The contract has a period of performance through October 5, 2023 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MICROGESTIN FE 1-20 TABLET 28S. The contract has a ceiling value of $1,159.34 and an ultimate completion date of December 1, 2023. This is a Firm Fixed Price Delivery Order contract, and there was no set-aside used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,514.81 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 27, 2023, with a completion date of September 28, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award, with identifier SPE2DB22D3501|SPE2DB23FXH95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,879.10 firm-fixed-price delivery order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product, with a completion date of September 25, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, SPE2DX15D7068|SPE2DX22F2JSB, was made by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $20,999.47, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution giant Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $7,097.68, is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product. The delivery order has an ultimate completion date of August 20, 2024 and was awarded on August 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor in the United States, has numerous...
The Defense Logistics Agency awarded a $5,462 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562052032 MICROGESTIN FE 1-20 TABLET 28S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide contraceptive pharmaceutical products to DLA locations in Conshohocken, Pennsylvania. Funding is being provided by DLA to support its medical supply chain requirements. No set aside designation or subcontracting details were...
This federal contract award, valued at $2,095.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which runs through November 2026. This IDC enables the company to provide a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency awarded a $865 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 28 strips of the prescription medication Microgestin FE 1.5-30. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 10-11, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime contractor on this delivery order placed...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQBC5
    Delivery Order

This federal contract award, valued at $1,139.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of March 5, 2025. The contract covers the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within the DLA Troop Support Medical. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated as a set-aside.

Generated 6/3/25, 9:43 AM